Munich Cancer Registry



Similar documents
Munich Cancer Registry

Munich Cancer Registry

Munich Cancer Registry

Munich Cancer Registry

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for

Measures of Prognosis. Sukon Kanchanaraksa, PhD Johns Hopkins University

UICC World Cancer Congress. Cancer Staging and Quality of Care

Table of Contents. I. Executive Summary A. Summary of our Findings II. Background III. Methodology IV. Key Data Sources...

PROTOCOL OF THE RITA DATA QUALITY STUDY

Secondary Cancer and Relapse Rates Following Radical Prostatectomy for Prostate-Confined Cancer

THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR)

Early mortality rate (EMR) in Acute Myeloid Leukemia (AML)

Mesothelioma in Northeastern Minnesota and Two Occupational Cohorts: 2007 Update. December 7, 2007

Mesothelioma in Northeastern Minnesota and Two Occupational Cohorts: 2007 Update. December 7, 2007

NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA)

Supplementary Online Content

The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales

Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization N = 50

Incorrect Analyses of Radiation and Mesothelioma in the U.S. Transuranium and Uranium Registries Joey Zhou, Ph.D.

Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer

Lung Cancer. Public Outcomes Report. Submitted by Omar A. Majid, MD

La sopravvivenza dei tumori maligni nei confronti internazionali: anticipazione della diagnosi o modifica del decorso naturale della malattia?

Rare Thoracic Tumours

Research Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma

Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008

Effect of Risk and Prognosis Factors on Breast Cancer Survival: Study of a Large Dataset with a Long Term Follow-up

(1) Comparison of studies with different follow-up periods

Mesothelioma in Australia: Incidence (1982 to 2013) and Mortality (1997 to 2012)


The Ontario Cancer Registry moves to the 21 st Century

DELRAY MEDICAL CENTER. Cancer Program Annual Report

National Cancer Institute

Chapter I Overview Chapter Contents

October is Breast Cancer Awareness Month!

Malignant Pleural Mesothelioma in Singapore

SPONTANEOUS MESOTHELIOMA DATA: AN INTERPRETATION. Robin Howie, Robin Howie Associates, Edinburgh.

Instructions for Filing Claims

Tips for surviving the analysis of survival data. Philip Twumasi-Ankrah, PhD

Cancer Data for South Florida: A Tool for Identifying Communities in Need

Burns and Roe Asbestos Personal Injury Settlement Trust Instructions for Filing Claims

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

Theories on Metastasis: Innovative Thinking An Advocacy Perspective

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

Disparities in Stage at Diagnosis, Survival, and Quality of Cancer Care in California by Source of Health Insurance

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON*

The Ontario Cancer Registry and its Data Quality. Diane Nishri Senior Research Associate, Surveillance February, 2011

ANNEX 2: Assessment of the 7 points agreed by WATCH as meriting attention (cover paper, paragraph 9, bullet points) by Andy Darnton, HSE

Instructions for Filing Asbestos Personal Injury Claims

Number. Source: Vital Records, M CDPH

A Cross-Sectional Study of Asbestos- Related Morbidity and Mortality in Vermonters Residing Near an Asbestos Mine November 3, 2008

Male. Female. Death rates from lung cancer in USA

Center Activity (07/01/ /30/2010) Center Region United States Tables for More Information

Collection and Use of Industry and Occupation Data III: Cancer surveillance findings among construction workers

If several different trials are mentioned in one publication, the data of each should be extracted in a separate data extraction form.

Ovarian Cancer. in Georgia, Georgia Department of Human Resources Division of Public Health

Stage 3 Lung Cancer - Know YourSurviving Conditions

Where Are Mesothelioma Claims Heading?

Instructions for Filing Unliquidated Asbestos Personal Injury Claims

Chapter 21: Managing Abstracting Assignments

Table 2.4. Summary of design and findings from mesothelioma case-control studies

Asbestos and Health WHO recommendations on elimination of asbestos-related diseases

Instructions for Filing Claims

Colorectal cancer. A guide for journalists on colorectal cancer and its treatment

Workers Compensation and Trust Fund Claims for Mesothelioma

chapter 5. Quality control at the population-based cancer registry

Dealing with Missing Data

The Belgian Asbestos Fund

Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD

EVALUATION/PRIORITIZATION CRITERIA: C, L, R, S *to meet requirement 1

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

Cancer in Ireland 2013: Annual report of the National Cancer Registry

Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科

Table of Contents. Acknowledgments. Executive Summary. Chapter 1: Introduction. Chapter 2: Cancer Incidence

Are Patients Diagnosed With Breast Cancer Before Age 50 Years Ever Cured? Hermann Brenner and Timo Hakulinen

Prostate cancer statistics

New Hampshire Childhood Cancer

Alaska Comprehensive Cancer Control Plan

Evaluation of Treatment Pathways in Oncology: Modeling Approaches. Feng Pan, PhD United BioSource Corporation Bethesda, MD

The New International Staging System Lung Cancer

Instructions for Filing Claims

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2009 MORTALITY 1997 TO 2011

Dictionary of SEER*Stat Variables November 2011 Submission (released April 2012) 1 of 18

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2008 MORTALITY 1997 TO 2007

BY THE NUMBERS: THE FUTURE OF MESOTHELIOMA IN AMERICA

Life Tables. Marie Diener-West, PhD Sukon Kanchanaraksa, PhD

Louisiana Cancer Facts & Figures Kidney Cancer 2016

Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group

Survival Rate of Childhood Leukemia in Shiraz, Southern Iran

BRAF as a prognostic marker in papillary thyroid cancer

Clinical Indications and Results Following Chest Wall Resection

Mesothelioma: Questions and Answers

Missing data and net survival analysis Bernard Rachet

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.

Evidence tabel Lokaal palliatieve behandelingen

Data Management & Analysis of the Focused Audits System

Asbestos-Related Cancer Research and Prevention

Instructions for Filing Unliquidated Asbestos Personal Injury Claims

Mesothelioma , The Patient Education Institute, Inc. ocft0101 Last reviewed: 03/21/2013 1

Transcription:

Munich Cancer Registry Baseline statistics Selection Matrix Homepage Deutsch Munich Cancer Registry at Munich Cancer Center Marchioninistr. 15 Munich, 81377 Germany http://www.tumorregister-muenchen.de/en Cancer statistics: Survival C45.: Pleural mesothelioma Year of diagnosis 1988-213 Patients 1,128 Diseases 1,129 Cases evaluated 5 Creation date 5/13/215 Export date 12//214 Population 4.64 m BERLIN GERMANY BAVARIA MUNICH http://www.tumorregister-muenchen.de/en/facts/surv/surv_c4_e.pdf

Survival C45.: Pleural mesothelioma Page 2 of 7 C45.: Mesothelioma of pleura Period of diagnosis % Relative survival 1988-213 N=5 9 4 2 1 Period of diagnosis 1988-1997 n= 12.5% 1998-26 n=316 56.4% 27+ n=174 31.1% SEER 1998-211 n=6,9 1 2 3 4 5 Years Figure 1a. Relative survival of patients with pleural mesothelioma by period of diagnosis. Included in the evaluation are 5 cases diagnosed between 1988 and 213. The survival results of the SEER program (Surveillance, Epidemiology, and End Results) of the American National Cancer Institute (NCI) are summarized as the period of diagnosis from 1998 to 211, and are represented by gray diamonds in order to facilitate comparisons between MCR and SEER. The presented survival curves are derived from clinical records with valid follow-up informations, which means that death certificate cases (DCO) cases are omitted from the analysis. With this one restriction, the MCR has provided populationbased statistics since 1988, collecting data on all cancer cases in the region of southern Bavaria. Historical data of previous time periods can be heavily selected, therefore, univariate survival comparisons of the presented time periods must be carefully considered. Nonetheless, all calculable survival curves are depicted to facilitate the comparison of long time follow-up analyses of relative survival between particular cancers. Period of diagnosis 1988-1997 1998-26 27+ n= n=316 n=174 Years obs. % rel. % obs. % rel. % obs. % rel. %...... 1 54.3 54.6 49.6 51.2 62. 63.7 2 25.7 26.3 25.3 26.6 29.5 31. 3 13.2 13.9 15.5 16.8 4 7.2 7.4 Table 1b. Observed (obs.) and relative (rel.) survival of patients with pleural mesothelioma by period of diagnosis for period 1988-213 (N=5).

Survival C45.: Pleural mesothelioma Page 3 of 7 C45.: Mesothelioma of pleura Gender % Survival 1988-213 N=5 Gender 9 Male n=463 82.7% Female n=97 17.3% 4 2 1 Observed Expected Relative 1 2 3 4 5 Years Figure 2a. Survival of patients with pleural mesothelioma by gender. Included in the evaluation are 5 cases diagnosed between 1988 and 213. Gender Male Female n=463 n=97 Years obs. % rel. % obs. % rel. %.... 1 54. 55.7 51.2 51.5 2 26.6 28. 26. 25.9 3 13.3 14.3 4 7.5 7.9 Table 2b. Observed (obs.) and relative (rel.) survival of patients with pleural mesothelioma by gender for period 1988-213 (N=5).

Survival C45.: Pleural mesothelioma Page 4 of 7 C45.: Mesothelioma of pleura Age category % Relative survival 1988-213 N=5 9 4 2 1 Age category -59 yrs n=115 2.5% -69 yrs n=211 37.7% + yrs n=234 41.8% 1 2 3 4 5 Years Figure 3a. Relative survival of patients with pleural mesothelioma by age category. Included in the evaluation are 5 cases diagnosed between 1988 and 213. Age category -59 yrs -69 yrs + yrs n=115 n=211 n=234 Years obs. % rel. % obs. % rel. % obs. % rel. %...... 1. 59.6 62.4 63.4 42. 44. 2 32.1 32.4 34.4 35.1 16.4 17.9 3 18.7 18.1 17.5 18. Table 3b. Observed (obs.) and relative (rel.) survival of patients with pleural mesothelioma by age category for period 1988-213 (N=5).

Survival C45.: Pleural mesothelioma Page 5 of 7 C45.: Mesothelioma of pleura Post-progression survival % Observed survival 1988-213 N=222 9 4 2 1 Type of progression All types n=222.% Locoregional progress n=38 17.1% 6 12 18 24 36 42 48 54 Months Figure 5a. Observed post-progression survival of 222 patients with pleural mesothelioma diagnosed between 1988 and 213 (incl. M1). These 222 patients with documented progression events during their course of disease represent 39.6% of the totally 5 evaluated cases. Patients with cancer relapse documented via death certificates only were excluded (n=218, 38.9%). Multiple progression types on different sites are included in the evaluation even when not occuring synchronously. Medical record documentation often lacks the linguistic severity to distinguish between local relapse, regional lymph node metastasis and distant spread in solid cancers. Frequently, the statement not specified is the only information in registries regarding relapse of the disease. The category All types denotes all cases who suffered from at least one relapse during the course of disease (incl. primary M1-status). Although, the real number of relapsed patients is likely to be much higher. The accumulated percentage of patients with local relapse or distant metastasis exceeds the % value because patients are potientially considered in more than one subgroup. Type of progression All types Locoregional progress n=222 n=38 Months % %.. 12 36.5 24 12.8 Table 5b. Observed post-progression survival of patients with pleural mesothelioma for period 1988-213 (N=222).

Survival C45.: Pleural mesothelioma Page 6 of 7 Shortcuts MCR Munich Cancer Registry, Germany (Tumorregister München) NCI National Cancer Institute, USA SEER Surveillance, Epidemiology, and End Results, USA UICC Union for International Cancer Control, Geneva DCO Death certificate only. The death certificate provides the only notification to the registry. NA Not available NOS Not otherwise specified OS Observed/overall survival (Kaplan-Meier estimate) RS Relative survival, compared to the general population, ratio of observed to expected survival (Ederer II method), reflecting excess mortality among cancer patients AS Assembled survival chart (observed, expected, relative) PPS Post-progression survival, survival since first relapse (Kaplan-Meier estimate) Date of entry: Date of first locoregional recurrence, distant metastasis, unspecified progression Event: Death of all causes CS Conditional survival, survival probability under the condition of surviving a given period of time Recommended Citation Munich Cancer Registry. Survival C45.: Pleural mesothelioma [Internet]. 215 [updated 215 May 13; cited 215 Jul 1]. Available from: http://www.tumorregister-muenchen.de/en/facts/surv/surv_c4_e.pdf Copyright The content of the public web site provided by the Munich Cancer Registry is available worldwide and free of charge. All documents are free to download, utilize, copy, print-out and distribute, providing that the MCR is referenced. Disclaimer The Munich Cancer Registry reserves the right to not be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.

Survival C45.: Pleural mesothelioma Page 7 of 7 Fig./Tbl. Index of figures and tables Page 1a Relative survival by period of diagnosis (chart) 2 1b Survival by period of diagnosis (table) 2 2a Survival by gender (chart) 3 2b Survival by gender (table) 3 3a Relative survival by age category (chart) 4 3b Survival by age category (table) 4 5a Observed post-progression survival (chart) 5 5b Observed post-progression survival (table) 5